Ventfort: clinical report on a tissue-derived preparation
Comparison in people · 2006
- What was studied
- 49 patients: 27 adjunctive Ventfort; 22 controls; ages 52–84, atherosclerosis or senile purpura.
- Main finding
- The 2005–2006 report describes lipid and capillary-fragility outcomes during 10–15 days of adjunctive care.
Study data at a glance
- Participants or experimental model
- 49 patients: 27 adjunctive Ventfort; 22 controls; ages 52–84, atherosclerosis or senile purpura.
- Reported results
- The 2005–2006 report describes lipid and capillary-fragility outcomes during 10–15 days of adjunctive care.
Study limitations and source details
Study limitations
- The table contains inconsistent sex subtotals. Lipid-table significance is relative to baseline; it does not establish fewer cardiovascular events.
- Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
- Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.
Source details
Institute report — commercial reproduction
Russian report reproduced on a commercial website; population, comparison and reported outcomes checked. Signed original and full protocol not authenticated.
Sources checked
Citation
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Ventfort: clinical report on a tissue-derived preparation Institute clinical report (commercial reproduction); 2006 study/report date, not website publication date